Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
In addition, there were significant associations between E-iAsing,rice and Sex, age, ethgrp5, nutrient intake, qual7 and E-iAsing,water with people taking higher level iAs from rice and rice products being generally younger, not White or having a higher education level.Characteristics of population satisfying inclusion criteria by hypertension status in the NDNS RP 7 to 8.Data from NDNS RP 7 to 8 (MRC Elsie Widdowson Laboratory and NatCen Social Research 2019) with exclusions as detailed in the text (N = 598)VariableGeneral hypertensionYes (N = 178)No (N = 420)p value*E-iAsing,rice (µg/person/day)2.17 (3.65)3.08 (5.11)0.015E-iAsing,water (µg/person/day)0.74 (0.70)1.02 (1.10)<0.001E-iAsing,grain (µg/person/day)2.69 (1.32)2.89 (1.47)0.100SexMale80 (44.94)171 (40.71)0.365Female98 (55.06)249 (59.29)surveyyr2014/1590 (50.56)203 (48.33)0.6552015/1688 (49.44)217 (51.67)HessConWith any physical/mental health condition/illnesses for 12 months or more98 (55.06)119 (28.33)< 0.001Without any physical/mental health condition/illnesses for 12 months or more80 (44.94)301 (71.67)Diabetes.combinedWithout diabetes149 (83.71)402 (95.71)< 0.001Diabetic29 (16.29)18 (4.29)NumChildHave no child152 (85.39)259 (61.67)< 0.001Have 1 to 2 child23 (12.92)143 (34.05)Have 3 to 4 child3 (1.69)18 (4.29)Age16: 34 years4 (2.25)151 (35.95)< 0.00135 to 49 years32 (17.98)130 (30.95)50 to 64 years71 (39.89)91 (21.67)65 + year71 (39.89)48 (11.43)QuarterSeason 129 (16.29)98 (23.33)0.217Season 245 (25.28)106 (25.24)Season 352 (29.21)101 (24.05)Season 452 (29.21)115 (27.38)WrkStatIn full: or part-time employment75 (42.13)259 (61.67)< 0.001Full-time student or not working103 (57.87)161 (38.33)ethgrp5White167 (93.82)383 (91.19)0.641Mixed1 (0.56)7 (1.67)Black or Black British2 (1.12)12 (2.86)Asian or Asian British6 (3.37)14 (3.33)Any other groups2 (1.12)4 (0.95)eqv3 (£)Lowest tertile (≤ 17,500)53 (29.78)94 (22.38)0.162Middle tertile (> 17,500 and ≤ 32,216)53 (29.78)135 (32.14)Highest tertile (> 32,500)72 (40.45)191 (45.48)cigsta3Current cigarette smoker19 (10.67)66 (15.71)< 0.001Ex-regular cigarette smoker62 (34.83)80 (19.05)Never regular cigarette smoker97 (54.49)274 (65.24)dnoft5: 7 days per week27 (15.17)32 (7.62)0.1233 to 4 days per week24 (13.48)48 (11.43)1 to 2 days per week44 (24.72)125 (29.76)1 to 2 per month27 (15.17)71 (16.90)Once every couples of months14 (7.87)47 (11.19)1 to 2 per year18 (10.11)45 (10.71)Not at all in the last 12 months/non-drinker24 (13.48)52 (12.38)bmival (kg/m2)Underweight: BMI < 18.50 (0.00)14 (3.33)< 0.001Normal (healthy weight): BMI between 18.5 and 2537 (20.79)172 (40.95)Overweight: BMI between 25 and 3074 (41.57)153 (36.43)Obese: BMI over 3067 (37.64)81 (19.29)whgvalFor male: less than 0.9; For female: less than 0.8028 (15.73)207 (49.29)< 0.001For male: more than and including 0.90, up to and including 1.00; for female: more than and including 0.80, up to and including 0.8554 (30.34)113 (26.90)For male: more than 1.00; for female: more than 0.8596 (53.93)100 (23.81)MNParticipants with 0 to 3 nutrients greater than or equal to the mean intake level34 (19.10)100 (23.81)0.736Participants with 4 to 7 nutrients greater than or equal to the mean intake level36 (20.22)81 (19.29)Participants with 8 to 11 nutrients greater than or equal to the mean intake level42 (23.60)101 (24.05)Participants with 12 to 15 nutrients greater than or equal to the mean intake level40 (22.47)84 (20.00)Participants with 16 to 18 nutrients greater than or equal to the mean intake level26 (14.61)54 (12.86)EnergyDkJ (KJ)Q1: 189.46 to 1294.8627 (15.17)52 (12.38)0.673Q2: 1295.07 to 1627.8733 (18.54)86 (20.48)Q3: 1628.14 to 2037.0152 (29.21)113 (26.90)Q4: 2037.83 to 4771.2866 (37.08)169 (40.24)ProteingD (g)Q1: 1.17 to 11.9021 (11.80)43 (10.24)0.338Q2: 11.91 to 15.4231 (17.42)91 (21.67)Q3: 15.43 to 19.3156 (31.46)107 (25.48)Q4: 19.33 to 69.0070 (39.33)179 (42.62)FatgD (g)Q1: 0.12 to 10.6434 (19.10)59 (14.05)0.466Q2: 10.65 to 14.2131 (17.42)83 (19.76)Q3: 14.23 to 18.7146 (25.84)110 (26.19)Q4: 18.74 to 59.8967 (37.64)168 (40.00)GlucosegD (g)Q1: 0.06 to 2.1941 (23.03)75 (17.86)0.543Q2: 2.20 to 3.3434 (19.10)88 (20.95)Q3: 3.35 to 4.8845 (25.28)115 (27.38)Q4: 4.89 to 30.2858 (32.58)142 (33.81)SodiummgD (mg)Q1: 22.97 to 327.8929 (16.29)62 (14.76)0.617Q2: 327.91 to 430.2333 (18.54)86 (20.48)Q3: 430.26 to 561.9656 (31.46)114 (27.14)Q4: 562.28 to 2306.8460 (33.71)158 (37.62)FolateugplussuppsD (µg)Q1: 5.69 to 35.3620 (11.24)54 (12.86)0.614Q2: 36.38 to 47.8530 (16.85)87 (20.71)Q3: 47.87 to 65.8152 (29.21)109 (25.95)Q4: 65.86 to 1426.3276 (42.70)170 (40.48)qual7Degree or equivalent47 (26.4)148 (35.24)0.084Higher education, below degree level; GCE, a level or equivalent35 (19.66)85 (20.24)GCSE grades A: G or equivalent/commercial qualifications/apprenticeship33 (18.54)77 (18.33)Foreign or other qualifications; no qualifications; still in FT education63 (35.39)110 (26.19)RegionEngland Central/Midlands27 (15.17)55 (13.1)0.395England North40 (22.47)99 (23.57)England South (including London)58 (32.58)162 (38.57)Northern Ireland and Scotland12 (6.74)32 (7.62)Wales41 (23.03)72 (17.14)SalHowCNever85 (47.75)209 (49.76)0.867Sometimes and usually43 (24.16)101 (24.05)Always50 (28.09)110 (26.19)The results were reported as means (standard deviations (SD)) for continuous variables (E-iAsing,rice, E-iAsing,water and E-iAsing,grain) or as frequencies (percentages (%)) for categorical ones (surveyyr, Quarter, Sex, age, ethgrp5, qual7, cigsta3 and eqv3, dnoft, HessCon, NumChild, Diabetes.combined, WrkStat, MN, EnergyDkJ, ProteingD, FatgD, GlucosegD, SodiummgD, FolateugplussuppsD, bmival, region, SalHowC and whgval)Differences were computed by hypertension status via χ2 tests and Wilcoxon rank-sum testsGeneral hypertension: whether participants were diagnosed as general hypertension; E-iAsing,rice: daily inorganic arsenic (iAs) intake from rice and rice products; E-iAsing,water: daily iAs intake from drinking water; E-iAsing,grain: daily iAs intake from grain and grain-based products; surveyyr: NDNS RP 7 to 8 survey year; Sex: gender; EnergyDkJ: intake of total energy per day (KJ) for diet only; ProteingD: intake of protein per day (g) for diet only; FatgD: intake of fat per day (g) for diet only; GlucosegD: intake of glucose per day (g) for diet only; SodiummgD: intake of sodium per day (mg) for diet only; FolateugplussuppsD: intake of folate (µg) per day for both diets and supplements; MN: daily intake of several micro-nutrients (Potassium (mg) including supplements, calcium (mg) including supplements, magnesium (mg) including supplements, iron (mg) including supplements, copper (mg) including supplements, zinc (mg) including supplements, retinol (mg) including supplements, vitamin A (retinol equivalents) (µg) including supplements, vitamin D (µg) including supplements, vitamin E (mg) including supplements, thiamin (mg) including supplements, riboflavin (mg) including supplements, niacin equivalent (mg) including supplements, vitamin B6 (mg) including supplements, vitamin B12 (µg) including supplements, vitamin C (mg) including supplements, iodine (µg) including supplements, selenium (µg) including supplements); region: country people live; NumChild: number of children aged between 0 and 15; age: age of respondent 16 + year old; SalHowC: how often salt added during cooking; Quarter: fieldwork quarter; qual7: qualifications gained; WrkStat: economic status (working condition); ethgrp5: ethnic group; eqv3: equivalized household income; HessCon: whether have any physical/mental health condition/illnesses for 12 months or more; Diabetes.combined: whether respondent is diabetic; cigsta3: cigarette smoking status; dnoft: frequency of alcohol consumption in past 12 months (including non-drinkers); bmival: BMI (kg/m2); whgval: waist-hip ratio groups*Indicating whether there is statistically significant relationship between characteristics of population and status of general hypertensionCharacteristics of population satisfying inclusion criteria by the distribution of E-iAsing,rice in the NDNS RP 7 to 8.Data from NDNS RP 7 to 8 (MRC Elsie Widdowson Laboratory and NatCen Social Research 2019) with exclusions as detailed in the text (N = 598)CharacteristicQuartile of E-iAsing,rice, µg/person/dayp value for trendQuartile 1 (0.00 to 0.00)N = 150Quartile 2 (0.00 to 0.565)N = 149p value*Quartile 3 (0.638 to 3.79)N = 149p value*Quartile 4 (3.79 to 41.8)N = 150p value*E-iAsing,grain (µg/person/day)2.98 (1.42)2.90 (1.48)0.9662.69 (1.38)0.3042.77 (1.43)0.5720.235E-iAsing,water (µg/person/day)0.72 (0.76)0.72 (0.70)0.8711.11 (1.22)0.0041.21 (1.15)< 0.001< 0.001SexFemale86 (57.33)93 (62.42)0.43693 (62.42)0.43675 (50.00)0.2470.006Male64 (42.67)56 (37.58)56 (37.58)75 (50.00)surveyyr2014/15132 (88.00)10 (6.71)< 0.00175 (50.34)< 0.00176 (50.67)< 0.0010.9692015/1618 (12.00)139 (93.29)74 (49.66)74 (49.33)HessConWithout any physical/mental health condition/illnesses for 12 months or more84 (56.00)100 (67.11)0.063102 (68.46)0.03695 (63.33)0.2900.461With any physical/mental health condition/illnesses for 12 months or more66 (44.00)49 (32.89)47 (31.54)55 (36.67)Diabetes combinedWithout diabetes139 (92.67)139 (93.29)0.733135 (90.60)0.663138 (92.00)0.8190.576Diabetic11 (7.33)10 (6.71)14 (9.40)12 (8.00)NumChildHave no child113 (75.33)100 (67.11)0.04497 (65.10)0.154101 (67.33)0.2910.900Have 1 to 2 child31 (20.67)47 (31.54)45 (30.20)43 (28.67)Have 3 to 4 child6 (4.00)2 (1.34)7 (4.70)6 (4.00)Age16: 3432 (21.33)35 (23.49)0.35445 (30.20)0.03243 (28.67)0.0030.00535 to 4930 (20.00)41 (27.52)41 (27.52)50 (33.33)50 to 6448 (32.00)39 (26.17)39 (26.17)36 (24.00)65+40 (26.67)34 (22.82)24 (16.11)21 (14.00)QuarterSeason 130 (20.00)32 (21.48)0.69528 (18.79)0.54337 (24.67)0.7880.992Season 239 (26.00)43 (28.86)30 (20.13)39 (26.00)Season 340 (26.67)36 (24.16)41 (27.52)36 (24.00)Season 441 (27.33)38 (25.50)50 (33.56)38 (25.33)WrkStatIn full: or part-time employment77 (51.33)79 (53.02)0.86087 (58.39)0.26791 (60.67)0.1310.053Full-time student or not working73 (48.67)70 (46.98)62 (41.61)59 (39.33)ethgrp5Any other group1 (0.67)2 (1.34)0.5480 (0.00)0.2323 (2.00)< 0.001< 0.001Asian or Asian British3 (2.00)3 (2.01)0 (0.00)14 (9.33)Black or Black British1 (0.67)2 (1.34)1 (0.67)10 (6.67)Mixed ethnic group0 (0.00)3 (2.01)1 (0.67)4 (2.67)White145 (96.67)139 (93.29)147 (98.66)119 (79.33)eqv3 (£)Lowest tertile (≤ 17,500)40 (26.67)38 (25.50)0.87332 (21.48)0.02337 (24.67)0.6410.787Middle tertile (> 17,500 and ≤ 32,216)53 (35.33)50 (33.56)37 (24.83)48 (32.00)Highest tertile (> 32,500)57 (38.00)61 (40.94)80 (53.69)65 (43.33)cigsta3Current cigarette smoker23 (15.33)20 (13.42)0.89223 (15.44)0.47519 (12.67)0.2970.182Ex-regular cigarette smoker40 (26.67)40 (26.85)31 (20.81)31 (20.67)Never regular cigarette smoker87 (58.00)89 (59.73)95 (63.76)100 (66.67)dnoftNot at all in the last 12 months/non-drinker24 (16.00)14 (9.40)0.21121 (14.09)0.59917 (11.33)0.2250.7491 to 2 per year19 (12.67)20 (13.42)11 (7.38)13 (8.67)1 to 2 per month13 (8.67)21 (14.09)12 (8.05)15 (10.00)Once every couples of months20 (13.33)26 (17.45)27 (18.12)25 (16.67)1 to 2 days per week43 (28.67)33 (22.15)42 (28.19)51 (34.00)3 to 4 days per week13 (8.67)20 (13.42)19 (12.75)20 (13.33)5 to 7 days per week18 (12.00)15 (10.07)17 (11.41)9 (6.00)bmival (kg/m2)Underweight: under 18.56 (4.00)4 (2.68)0.1172 (1.34)0.2142 (1.33)0.1790.872Normal (healthy weight): 18.5 and below 2542 (28.00)59 (39.60)52 (34.90)56 (37.33)Overweight: 25 and below 3060 (40.00)54 (36.24)63 (42.28)50 (33.33)Obese: over 3042 (28.00)32 (21.48)32 (21.48)42 (28.00)whgvalFor male: less than 0.9; For female: less than 0.8050 (33.33)61 (40.94)0.35459 (39.60)0.12365 (43.33)0.2040.321For male: more than and including 0.90, up to and including 1.00; For female: more than and including 0.80, up to and including 0.8542 (28.00)40 (26.85)49 (32.89)36 (24.00)For male: more than 1.00; for female: more than 0.8558 (38.67)48 (32.21)41 (27.52)49 (32.67)MNParticipants with 0 to 3 nutrients greater than or equal to the mean intake level38 (25.33)34 (22.82)0.67836 (24.16)0.88126 (17.33)0.3290.007Participants with 4 to 7 nutrient 4 greater than or equal to the mean intake level25 (16.67)32 (21.48)30 (20.13)30 (20.00)Participants with 8 to 11 nutrients greater than or equal to the mean intake level36 (24.00)41 (27.52)33 (22.15)33 (22.00)Participants with 12 to 15 nutrients greater than or equal to the mean intake level29 (19.33)23 (15.44)32 (21.48)40 (26.67)Participants with 16 to 18 nutrients greater than or equal to the mean intake level22 (14.67)19 (12.75)18 (12.08)21 (14.00)EnergyDkJ (KJ)Q1: 189.46 to 1294.8628 (18.67)18 (12.08)0.22121 (14.09)0.43212 (8.00)0.0120.013Q2: 1295.07 to 1627.8733 (22.00)32 (21.48)30 (20.13)24 (16.00)Q3: 1628.14 to 2037.0133 (22.00)46 (30.87)44 (29.53)42 (28.00)Q4: 2037.83 to 4771.2856 (37.33)53 (35.57)54 (36.24)72 (48.00)ProteingD (g)Q1: 1.17 to 11.9017 (11.33)20 (13.42)0.43917 (11.41)0.93310 (6.67)0.0440.045Q2: 11.91 to 15.4238 (25.33)27 (18.12)34 (22.82)23 (15.33)Q3: 15.43 to 19.3137 (24.67)44 (29.53)41 (27.52)41 (27.33)Q4: 19.33 to 69.0058 (38.67)58 (38.93)57 (38.26)76 (50.67)FatgD (g)Q1: 0.12 to 10.6422 (14.67)19 (12.75)0.03429 (19.46)0.59123 (15.33)0.1270.592Q2: 10.65 to 14.2136 (24.00)21 (14.09)36 (24.16)21 (14.00)Q3: 14.23 to 18.7131 (20.67)50 (33.56)33 (22.15)42 (28.00)Q4: 18.74 to 59.8961 (40.67)59 (39.60)51 (34.23)64 (42.67)GlucosegD (g)Q1: 0.06 to 2.1934 (22.67)34 (22.82)0.98626 (17.45)0.45222 (14.67)0.3020.269Q2: 2.20 to 3.3429 (19.33)29 (19.46)31 (20.81)33 (22.00)Q3: 3.35 to 4.8835 (23.33)37 (24.83)45 (30.20)43 (28.67)Q4: 4.89 to 30.2852 (34.67)49 (32.89)47 (31.54)52 (34.67)SodiummgD (mg)Q1: 22.97 to 327.8924 (16.00)22 (14.77)0.50323 (15.44)0.73722 (14.67)0.2160.317Q2: 327.91 to 430.2336 (24.00)27 (18.12)29 (19.46)27 (18.00)Q3: 430.26 to 561.9644 (29.33)44 (29.53)44 (29.53)38 (25.33)Q4: 562.28 to 2306.8446 (30.67)56 (37.58)53 (35.57)63 (42.00)FolateugplussuppsD (µg)Q1: 5.69 to 35.3617 (11.33)20 (13.42)0.77022 (14.77)0.44415 (10.00)0.0490.313Q2: 36.38 to 47.8532 (21.33)36 (24.16)23 (15.44)26 (17.33)Q3: 47.87 to 65.8133 (22.00)34 (22.82)39 (26.17)55 (36.67)Q4: 65.86 to 1426.3268 (45.33)59 (39.60)65 (43.62)54 (36.00)qual7Foreign or other qualifications; No qualifications; Still in FT education48 (32.00)47 (31.54)0.70142 (28.19)0.90136 (24.00)0.2660.025GCSE grades A: G or equivalent/commercial qualifications/apprenticeship27 (18.00)33 (22.15)28 (18.79)22 (14.67)Higher education, below degree level; GCE, A level or equivalent28 (18.67)30 (20.13)28 (18.79)34 (22.67)Degree or equivalent47 (31.33)39 (26.17)51 (34.23)58 (38.67)RegionEngland Central/Midlands25 (16.67)21 (14.09)0.61816 (10.74)0.09920 (13.33)0.4420.155England North40 (26.67)36 (24.16)27 (18.12)36 (24.00)England South (including London)46 (30.67)56 (37.58)59 (39.60)59 (39.33)Northern Ireland and Scotland8 (5.33)11 (7.38)14 (9.40)11 (7.33)Wales31 (20.67)25 (16.78)33 (22.15)24 (16.00)SalHowCNever76 (50.67)68 (45.64)0.23086 (57.72)0.43164 (42.67)0.3810.088Sometimes and usually38 (25.33)32 (21.48)30 (20.13)44 (29.33)Always36 (24.00)49 (32.89)33 (22.15)42 (28.00)The results were reported as means (standard deviations (SD)) for continuous variables (E-iAsing,water and E-iAsing,grain) or as frequencies (percentages (%)) for categorical ones (surveyyr, quarter, sex, age, ethgrp5, qual7, cigsta3 and eqv3, dnoft, HessCon, NumChild, Diabetes.combined, WrkStat, MN, EnergyDkJ, ProteingD, FatgD, GlucosegD, SodiummgD, FolateugplussuppsD, bmival, region, SalHowC and whgval)Differences across quartiles were computed by exposure categories via χ2 tests or Wilcoxon rank-sum tests with Tukey post hoc test. p values for trend were obtained from analysis of variance (ANOVA) test with type II error where the characteristic factors were treated as continuous variables, indicating whether or not there is a statistically significant relationship between those characteristics of the population and iAs intakeE-iAsing,rice: daily inorganic arsenic (iAs) intake from rice and rice products; E-iAsing,water: daily iAs intake from drinking water; E-iAsing,grain: daily iAs intake from grain and grain-based products; surveyyr: NDNS RP 7 to 8 Survey year; Sex: gender; EnergyDkJ: intake of total energy per day (KJ) for diet only; ProteingD: intake of protein per day (g) for diet only; FatgD: intake of fat per day (g) for diet only; GlucosegD: intake of glucose per day (g) for diet only; SodiummgD: intake of sodium per day (mg) for diet only; FolateugplussuppsD: intake of folate (µg) per day for both diets and supplements; MN: daily intake of several micro-nutrients (potassium (mg) including supplements, calcium (mg) including supplements, magnesium (mg) including supplements, iron (mg) including supplements, copper (mg) including supplements, zinc (mg) including supplements, retinol (mg) including supplements, vitamin A (retinol equivalents) (µg) including supplements, vitamin D (µg) including supplements, vitamin E (mg) including supplements, thiamin (mg) including supplements, riboflavin (mg) including supplements, niacin equivalent (mg) including supplements, vitamin B6 (mg) including supplements, vitamin B12 (µg) including supplements, vitamin C (mg) including supplements, iodine (µg) including supplements, selenium (µg) including supplements); region: country people live; NumChild: number of children aged between 0 and 15; age: age of respondent 16 + ; SalHowC: how often salt added during cooking; Quarter: fieldwork quarter; qual7: qualifications gained; WrkStat: Economic status (working condition); ethgrp5: ethnic group; eqv3: equivalized household income; HessCon: whether have any physical/mental health condition/illnesses for 12 months or more; Diabetes.combined: whether respondent is diabetic; cigsta3: cigarette smoking status; dnoft: frequency of alcohol consumption in past 12 months (including non-drinkers); bmival: BMI (kg/m2); whgval: waist-hip ratio groups*Compared with Quartile 1 (referent group) (0.00 to 0.00 µg/person/day)
Source: Characteristics of E-iAsing,rice, hypertension risks and all the potential confounders. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
To address this, we conducted an individual-level cross-sectional analysis to quantify the extent to which daily iAs intake from rice and rice products (E-iAsing,rice) modifies the association between hypertension risks and previously well-established risk factors.
Source: Abstract.
During the study period, a representative sample of 2723 participants aged 1.5 and older was recruited.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Exploratory study of the association in the United Kingdom between hypertension and inorganic arsenic (iAs) intake from rice and rice products
Cross-sectional study · Environmental Geochemistry and Health · 2020
Original publication title
Exploratory study of the association in the United Kingdom between hypertension and inorganic arsenic (iAs) intake from rice and rice products
© The Author(s) 2020
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: Electronic supplementary material
The online version of this article (10.1007/s10653-020-00573-8) contains supplementary material, which is available to authorized users.
Source: Electronic supplementary materialAuthors’ abstract
Hypertension risks arising from chronic exposure to inorganic arsenic (iAs) are well documented. Consumption of rice is a major iAs exposure route for over 3 billion people; however, there is a lack of epidemiological evidence demonstrating an association of hypertension risks with iAs intake from rice, especially in areas where there is little exposure from drinking water but a growing demand for rice intake. To address this, we conducted an individual-level cross-sectional analysis to quantify the extent to which daily iAs intake from rice and rice products (E-iAsing,rice) modifies the association between hypertension risks and previously well-established risk factors.
The analysis was based on secondary dietary, socio-demographic and health status data of 598 participants recorded in the UK National Diet and Nutrition Survey 2014 to 2016. E-iAsing,rice and five blood pressure endpoints were derived with potential associations explored through generalized linear models. According to the results, a negative but not significant relationship was found between hypertension risks and E-iAsing,rice after adjusting for major risk factors, notably age, gender, diabetes and obesity, with relatively higher risks being observed for male, middle-aged, overweight, alcohol consumer or Asian or Asian British, Black or Black British and mixed ethnic groups.
Though inconclusive and mainly limited by potential incomplete adjustment for major confounders and intrinsic disadvantages of a cross-sectional design, this study was the first quantifying the individual level dose: response relationship between E-iAsing,rice and hypertension risks and is consistent with previous studies on the limited associations of hypertension with low-level arsenic exposure from drinking water. Larger scale cohort studies are indicated to quantify the association but in any event it is likely to be weak.
Electronic supplementary material
The online version of this article (10.1007/s10653-020-00573-8) contains supplementary material, which is available to authorized users.
Publication and source details
Original title: Exploratory study of the association in the United Kingdom between hypertension and inorganic arsenic (iAs) intake from rice and rice products
Lingqian Xu; David A. Polya
Environmental Geochemistry and Health · 2020
© The Author(s) 2020https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.University of Manchester Presidents Doctoral ScholarshipXu LingqianRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T17:49:00.382767+00:00
DOI: 10.1007/s10653-020-00573-8 · PMC8275557